Sorrento Therapeutics Gets $2.3M
socalTECH
JUNE 19, 2009
San Diego-based Sorrento Therapeutics , a new biotechnology startup, has raised $2.3M in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom.
100 
Let's personalize your content